Evidence map›Paper›PMID 11113178›Full record

ArticleMolecular and cellular biology2001

Insulin receptor substrate 3 (IRS-3) and IRS-4 impair IRS-1- and IRS-2-mediated signaling.

K Tsuruzoe, R Emkey, K M Kriauciunas, K Ueki, C R Kahn

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2001. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 112 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Preeclampsia as a Study Model for Aging: The Klotho Gene Paradigm.International journal of molecular sciences · 2025
    Review
  5. Review
  6. Is MG53 a potential therapeutic target for cancer?Frontiers in endocrinology · 2023
    Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. CDK4 is an essential insulin effector in adipocytes.The Journal of clinical investigation · 2016
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

K TsuruzoeResearch Division, Joslin Diabetes Center, Department of Medicine, Harvard Medical School, Boston, Massachusetts 02215, USA.
R Emkey
K M Kriauciunas
K Ueki
C R Kahn
Joslin Diabetes Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Insulin Receptor Substrates and Insulin ActionR01DK033201 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1986 to 2016
$10.6M
Role of PI 3-Kinase Isoforms in Insulin ActionR01DK055545 · NIDDK · JOSLIN DIABETES CENTER · PI KAHN, C RONALD · 1999 to 2020
$8.3M
NIDDK NIH HHS DK33201NIDDK NIH HHS DK36836NIDDK NIH HHS DK55545NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK033201NIDDK NIH HHS R01 DK055545
6 · The paper itself

Abstract

To investigate the roles of insulin receptor substrate 3 (IRS-3) and IRS-4 in the insulin-like growth factor 1 (IGF-1) signaling cascade, we introduced these proteins into 3T3 embryonic fibroblast cell lines prepared from wild-type (WT) and IRS-1 knockout (KO) mice by using a retroviral system. Following transduction of IRS-3 or IRS-4, the cells showed a significant decrease in IRS-2 mRNA and protein levels without any change in the IRS-1 protein level. In these cell lines, IGF-1 caused the rapid tyrosine phosphorylation of all four IRS proteins. However, IRS-3- or IRS-4-expressing cells also showed a marked decrease in IRS-1 and IRS-2 phosphorylation compared to the host cells. This decrease was accounted for in part by a decrease in the level of IRS-2 protein but occurred with no significant change in the IRS-1 protein level. IRS-3- or IRS-4-overexpressing cells showed an increase in basal phosphatidylinositol 3-kinase activity and basal Akt phosphorylation, while the IGF-1-stimulated levels correlated well with total tyrosine phosphorylation level of all IRS proteins in each cell line. IRS-3 expression in WT cells also caused an increase in IGF-1-induced mitogen-activated protein kinase phosphorylation and egr-1 expression ( approximately 1.8- and approximately 2.4-fold with respect to WT). In the IRS-1 KO cells, the impaired mitogenic response to IGF-1 was reconstituted with IRS-1 to supranormal levels and was returned to almost normal by IRS-2 or IRS-3 but was not improved by overexpression of IRS-4. These data suggest that IRS-3 and IRS-4 may act as negative regulators of the IGF-1 signaling pathway by suppressing the function of other IRS proteins at several steps.

Indexed as

Protein Serine-Threonine KinasesSignal Transduction3T3 CellsAdaptor Proteins, Signal TransducingAnimalsDNAGene DeletionGenes, Immediate-EarlyHumansInsulin-Like Growth Factor IInsulin Receptor Substrate ProteinsIntracellular Signaling Peptides and ProteinsMAP Kinase Signaling SystemMiceMice, KnockoutPhosphatidylinositol 3-KinasesAdaptor Proteins, Signal TransducingAKT1 protein, humanDNAInsulin-Like Growth Factor IInsulin Receptor Substrate ProteinsIntracellular Signaling Peptides and ProteinsIRS1 protein, humanIrs1 protein, mouseIRS2 protein, humanIrs2 protein, mouseIRS3P protein, humanIrs3 protein, mouseIRS4 protein, humanIrs4 protein, mousePhosphatidylinositol 3-KinasesPhosphoproteinsPhosphotyrosineProtein Serine-Threonine KinasesProto-Oncogene ProteinsProto-Oncogene Proteins c-aktRNA, Messenger

Identifiers

PMID11113178
PMCPMC86565
OpenAlexW2098324895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.